Completed OBSERVATIONAL NCT00003863

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Genetic Changes in Diffuse Aggressive Non-Hodgkin's Lymphoma

Sponsor: Alliance for Clinical Trials in Oncology

Conditions Lymphoma

Interventions comparative genomic hybridization cytogenetic analysis fluorescence in situ hybridization gene rearrangement analysis

Updated 11 times since 2017 Last updated: Jul 1, 2016 Started: Jun 30, 1999 Primary completion: May 31, 2005 Completion: May 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00003863, this observational or N/A phase trial focuses on Lymphoma and remains completed. Sponsored by Alliance for Clinical Trials in Oncology, it has been updated 11 times since 1999, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed

▶ Show 6 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed
Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Jun 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Data source: Alliance for Clinical Trials in Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anniston, United States , Asheville, United States , Baltimore, United States , Boston, United States , Buffalo, United States , Burlington, United States , Camden, United States , Chapel Hill, United States , Charlottesville, United States , Chicago, United States and 45 more locations